Table 1 Baseline clinical characteristics of the study participants
Characteristics | CAD patients | Controls | P value |
|---|---|---|---|
(n = 653) | (n = 646) | ||
Age (years) | 68.16 ± 9.42 | 65.57 ± 10.57 | < 0.001 |
SBP (mm Hg) | 141.06 ± 22.78 | 127.07 ± 15.37 | < 0.001 |
DBP (mm Hg) | 81.44 ± 13.96 | 79.74 ± 12.78 | 0.020 |
Hypertension (%) | 441 (67.53) | 290 (44.89) | < 0.001 |
Diabetes mellitus (%) | 223 (34.15) | 139 (21.55) | < 0.001 |
Hyperhomocysteinemia (%) | 83 (12.71) | 19 (2.94) | < 0.001 |
Hyperuricemia (%) | 80 (12.25) | 16 (2.48) | < 0.001 |
Hyperlipidemia (%) | 238 (36.45) | 113 (17.49) | < 0.001 |
Uric Acid (μmol/L) | 349.66 ± 113.79 | 290.77 ± 116.53 | < 0.001 |
TG (mmol/L) | 2.08 ± 1.74 | 1.89 ± 1.22 | 0.080 |
TC (mmol/L) | 5.39 ± 1.23 | 4.97 ± 1.39 | < 0.001 |
LDL-C (mmol/L) | 3.05 ± 0.88 | 2.80 ± 0.89 | < 0.001 |
HDL-C (mmol/L) | 1.26 ± 0.33 | 1.28 ± 0.42 | 0.330 |